Status:

COMPLETED

An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma

Lead Sponsor:

Bristol-Myers Squibb

Conditions:

Melanoma

Skin Cancer

Eligibility:

All Genders

12+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to see if BMS-986205 combined with nivolumab, compared to nivolumab by itself, is more effective in treating Melanoma that has spread or is unable to be removed by surgery...

Eligibility Criteria

Inclusion

  • For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
  • 12 years and older unless not permitted by local regulations; in that case 18 years old and older
  • Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to 1
  • Histologically confirmed Stage III (unresectable) or Stage IV melanoma, per the American Joint Committee on Cancer (AJCC) Staging Manual (8th edition)
  • Treatment-naïve participants (no prior systemic anticancer therapy for unresectable or metastatic melanoma)
  • Measurable disease per RECIST v1.1

Exclusion

  • Active brain metastases or leptomeningeal metastases
  • Uveal or ocular melanoma
  • Participants with active, known, or suspected autoimmune disease
  • Prior malignancy active within the previous 3 years except for locally curable cancers that have been apparently cured
  • Other protocol defined inclusion/exclusion criteria could apply

Key Trial Info

Start Date :

November 30 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 2 2020

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03329846

Start Date

November 30 2017

End Date

July 2 2020

Last Update

July 9 2021

Active Locations (63)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 16 (63 locations)

1

Angeles Clinic and Research Institute

Los Angeles, California, United States, 90025

2

University Of Colorado

Aurora, Colorado, United States, 80045

3

Mount Sinai Comprehensive Cancer Center

Miami Beach, Florida, United States, 33140

4

University Of Chicago

Chicago, Illinois, United States, 60637